Stimulants and stress can each induce sensitization, which may be crucial in the development of stimulantinduced psychosis and schizophrenia. Stressful experiences, together with methamphetamine use, may induce stress sensitization associated with noradrenergic hyperactivity and increased dopamine activity (release). This sensitization may be central to spontaneous recurrences of methamphetamine psychosis. Sensitization to the psychosis-induced effects of cocaine may be related to severe addiction. A combination of developmental (normative life events) and degenerative events (deficiency in neuronal modulatory capacity) may mostly cause neurochemical sensitization, which then can lead to the onset and progress to treatment resistance and clinical deterioration, subsequently inducing a self-limiting neurodegenerative phase in schizophrenia. To study the pathophysiology of schizophrenia, turning preference to the left, which was induced by stimulants such as phencyclidine and MK-801 in animals possibly through an asymmetry in dopaminergic function in the globus pallidus and found in schizophrenic patients, can serve as a new animal model.
PERSPECTIVE

It all sticks together-the APP-related family of proteins and Alzheimer's disease TA Bayer, R Cappai, CL Masters, K Beyreuther, G Multhaup
Alzheimer's disease is the most common form of dementia affecting elderly people. In all forms of the disease, accumulating evidence supports the hypothesis that cerebral amyloid A␤ protein deposition is the essential pathogenic event. The major component of amyloid plaque proteins, A␤, is derived from the transmembrane amyloid precursor protein (APP). APP belongs to the APP family, a group of related proteins that are evolutionarily well-conserved, functionally related and potentially important. These proteins named APP, APLP1 and APLP2 share similar functions, eg in the processing of information and memory. The authors assume that a loss of function of these proteins leads to a gradual cognitive decline observed in patients with Alzheimer's disease. All members of this protein family seem to participate in this pathological process. Further understanding of the biological function of these proteins may provide novel therapeutic approaches to prevent or ameliorate the disease state before the neurotoxic events become irreversible.
MILLENNIUM ARTICLE
Dopamine D 4 receptors: significance for molecular psychiatry at the millennium FI Tarazi, RJ Baldessarini
Cloning the D 4 receptor gene, and discovery that the highly clinically effective, atypical antipsychotic clozapine exhibits high affinity and moderate selectivity for D 4 receptors, together with the reported elevation of these receptors in postmortem schizophrenic brain tissue promised a major breakthrough in understanding the pathophysiology of schizophrenia and its treatment. However, these findings were followed by inconsistent postmortem neuropathological findings, lack of association between the D 4 receptor gene and schizophrenia, and failure of two clinical trials involving D 4 -selective agents to improve the psychotic symptoms in schizophrenic patients. Other recent studies indicate relationships betweem D 4 receptor genes and attention deficit hyperactivity disorders, mood disorders, and Parkinson's disease, and suggest that D 4 receptors may have broader implications for human illnesses. Postmortem studies on brain tissue from patients diganosed with these neuropsychiatric disorders are needed to clarify the role of D 4 receptors in their pathophysiology and potential treatment because D 4 -selective compounds might be clinically useful in neuropsychiatric disorders other than schizophrenia.
ORIGINAL RESEARCH ARTICLES
Association between variants at the GABA A ␤2, GABA A ␣6 and GABA A ␥2 gene cluster and alcohol dependence in a Scottish population E-W Loh, I Smith, R Murray, M McLaughlin, S McNulty, D Ball There are several lines of evidence suggesting that the GABA neurotransmitter system is involved in alcohol dependence syndrome. Therefore genes encoding the GABA/benzodiazepine receptor complex represent strong candidate genes for a genetic predisposition to alcohol dependence syndrome. To elucidate the potential role of GABA A subunits in human alcohol depen-dence syndrome, the authors identified polymorphisms in the GABA A ␤2 and GABA A ␣6 receptor subunit genes and assessed their potential contribution in an association study, together with a previously reported polymorphism at the GABA A ␥2 receptor subunit. These subunit genes are clustered together on chromosome 5. These findings provide preliminary evidence for a role for the GABA A receptor subunit cluster on chromosome 5q33 in susceptibility to the alcohol dependence syndrome and Korsakoff's psychosis. Bipolar affective disorder (BPAD) is a common mood disorder affecting around 1% of the population. Due to the chronicity and disabling nature of the disease accompanied by a high suicide risk and often severe social implications, BPAD constitutes a major health problem for the affected individuals, their families, and the society. There is strong evidence of a major genetic component in the etiology of BPAD, and susceptibility to the disease is most likely determined by several genes. Dopa decarboxylase (DDC) is an enzyme required in the synthesis of important brain substances (neurotransmitters and neuromodulators) involved in the regulation of mood. The authors have identified two variations in the gene encoding DDC that may influence the level of expression of the gene. Analyzing these two DDC gene variants in an association study of 192 BPAD patients and 572 controls, they have obtained evidence suggesting that one of the variants confers susceptibility to BPAD. This susceptibility variant may account for around 4% of all BPAD cases. The identification of the genetic background for BPAD will eventually allow a more rational diagnosis and treatment of this and related disorders. Dopaminergic systems play an important role in drug reward and reinforcement, therefore attention is focused on genes expressed in these circuits as candidates contributing to alcoholism. There is a 40-bp VNTR polymorphism in the 3Ј-untranslated region (3Ј-UTR) of the dopamine transporter (DAT1) gene, and several groups reported the association of the VNTRpolymorphism and alcoholism. In the present study, a novel polymorphism in the 3Ј-UTR of the DAT1 gene, G2319A, was identified and a significant association between the polymorphism and alcoholism was observed. There was a significant gene dose effect on the risk for alcoholism associated with the 2319-A allele. Moreover, in the haplotype analysis with the VNTR polymorphism, a positive gene dose effect on the risk with the A10 allele and a negative effect with the G10 allele for alcoholism were significantly detected. These results indicate that the DAT1 gene may confer vulnerability to alcoholism.
Two novel variants in the
Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5 G Kirov, I Jones, F McCandless, N Craddock, MJ Owen
The dopaminergic system has been implicated in the aetiology of mood disorders. The authors conducted family-based association studies for polymorphisms at three genes involved in the metabolism of dopamine: dopamine transporter (DAT1), dopamine bhydroxylase (DBH) and catechol-O-methyl transferase (COMT); and three dopamine receptors: DRD2, DRD3 and DRD5. In order to reduce the chances of producing false-positive results, the authors used a sample of 122 parent-offspring trios of British Caucasian origin where the proband had bipolar disorder 1 (BPI) and DNA from both parents was also available. The results were analysed with the Transmission/disequilibrium test (TDT) which examines whether parents who are heterozygous (have two different alleles at the same locus), are more likely to transmit one of these alleles to their affected child. No statistically significant differences were found between transmitted and not transmitted alleles for any of the polymorphisms studied which suggests that they do not increase the risk of developing bipolar affective disorder.
Detection of Borna disease virus RNA from peripheral blood cells in schizophrenia patients and mental health workers C-H Chen, Y-L Chiu, C-K Shaw, M-T Tsai, A-L Hwang, K-J Hsiao
Accumulating evidence suggests that Borna disease virus (BDV), a neurotropic, negative-stranded RNA virus, might be associated with certain human mental disorders. In the authors' previous study they demonstrated a significantly higher seroprevalence of BDV antibodies among schizophrenic patients than in nonpsychiatric controls in the Taiwanese population. In this study, they further investigated the detection rate of BDV RNA from the peripheral blood cells of their schizophrenic patients. By using the reverse transcription-polymerase chain reaction (RT-PCR) method, they detected a significantly higher presence of BDV RNA in schizophrenic patients than in non-psychiatric controls (14% vs 1.4%, PϽ0.01). Furthermore, a higher BDV RNA detection rate among mental health workers than in controls was noted (15% vs 1.4%, PϽ0.001). These data add further support that BDV infection might play a role in the pathogenesis of schizophrenia in the Taiwanese population, and suggest that people in close contact with mental patients might have a higher rate of BDV infection.
(+) 3,4-Methylenedioxymethamphetamine ('Ecstasy') transiently increases striatal 5-HT 1B binding sites without altering 5-HT 1B mRNA in rat brain TJ Sexton, C McEvoy, JF Neumaier MDMA (ecstasy) is a commonly abused psychedelic drug that can induce degeneration of the serotonin neurotransmitter system in the brain. Ecstasy abusers can develop long-term psychiatric problems, but the mechanism of this problem is not understood. Previous studies in rats suggested that MDMA's behavioral effects involve 5-HT 1B serotonin receptors. In this study the authors tested whether a range of MDMA doses would alter 5-HT 1B receptor regulation in several brain regions immediately and 2 weeks after MDMA treatment. They found that high dose MDMA caused a transient doubling of 5-HT 1B receptor density in the striatum, a brain region that may be involved in hyperactivity and perhaps reinforcement of drug use. These results suggest that 5-HT 1B receptors may play an important role in the acute effects of MDMA, but these receptors are probably not involved in the long-term changes that MDMA causes, as 5-HT 1B receptor levels normalized by 2 weeks after MDMA treatment.
The DRD2 Taq1 polymorphism and symptoms of attention deficit hyperactivity disorder DC Rowe, EJCG Van den Oord, C Stever, LN Giedinghagen, JMC Gard, HH Cleveland, M Gilson, ST Terris, JH Mohr, S Sherman, A Abramowitz, ID Waldman The dopamine D2 receptor gene (DRD2) is involved in nervous system pathways that underlie the brain's response to novelty and reward. Previous studies have examined the relation between the DRD2 Taq1 A1 and A2 variants and a number of psychiatric disorders. Most studies have found either no relation or that the rarer A1 allele is the risk-inducing allele for psychiatric disorders. The authors examined the relation between the Taq1 marker in DRD2 and attention deficit hyperactivity disorder (ADHD) symptoms in children. The surprising result was that levels of ADHD symptoms were higher in children with more copies of the A2 variant. Tests of linkage between DRD2 and ADHD were also conducted but no evidence for linkage was found. Given both the absence of linkage, and association with the putatively low-risk allele, it is doubtful that this DRD2 variant influences childhood ADHD.
Evidence for the segregation of a major gene for human plasma GABA levels F Petty, M Fulton, GL Kramer, M Kram, LL Davis, AJ Rush Gamma-aminobutyric acid (GABA) is a major neurotransmitter in the central nervous system, and plasma levels of GABA may reflect brain GABA activity. In a subgroup of patients with mood disorders, low plasma GABA has characteristics of a biological trait marker. The authors conducted a segregation analysis of plasma GABA levels in a sample of 157 individuals from 50 nuclear families. Analysis indicated that the familial transmission of plasma GABA levels is compatible with the segregation of a recessive major gene. These results suggest that plasma GABA levels are under single gene control. Future research should address the precise mechanisms which may account for the abnormality in GABA levels seen in a subset of patients with mood disorders. If the regulation of extracellular GABA levels is under genetic control, as suggested by this study, appropriate candidate genes should be examined in persons with mood disorders and low plasma GABA.
